Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.

Research output: Contribution to journalArticle


Gastric and esophageal adenocarcinomas are major global cancer burdens. These cancer forms are characterized by a poor prognosis and a modest response to chemo- radio- and targeted treatment. Hence there is an obvious need for further enhanced diagnostic and treatment strategies. The aim of this study was to examine the expression and prognostic impact of human epidermal growth factor receptor 1 (HER1/EGFR) and 3 (HER3), as well as the occurrence of EGFR and KRAS mutations in gastric and esophageal adenocarcinoma.


Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Article numbere0148101
JournalPLoS ONE
Issue number2
Publication statusPublished - 2016
Publication categoryResearch

Related research output

CHARLOTTA HEDNER, 2016, Lund: Lund University, Faculty of Medicine. 78 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)